The Scientific Advisory Board (SAB) of the Foundation reads as a Who’s Who of CLL research. The SAB sets research priorities targeting critical unmet needs in CLL, and oversee the funding process from initial requests for applications through award notification, ensuring funded projects are of the highest order of integrity and originality.
Michael Keating, M.B.,B.S.
Professor, Department of Leukemia
University of Texas MD Anderson Cancer Center
William Wierda, M.D., Ph.D.
Professor, Department of Leukemia
University of Texas MD Anderson Cancer Center
William Plunkett, Ph.D.
Professor, Department of Experimental Therapeutics
University of Texas MD Anderson Cancer Center
Nicholas Chiorazzi, M.D.
Professor, Institute of Molecular Medicine for Medical Research
Feinstein Institute for Medical Research – Northwell Health
Steve Winfield
CLL Global Board Member
